Balancing Cost and Quality in the Pharmaceutical Supply Chain: A Quick Guide

A woman presenting data on balancing cost and quality in the pharma supply chain.
In the life-science industry, finding the right balance between cost and quality in the supply chain is crucial. This balance ensures that pharma companies remain financially healthy while delivering safe and effective products to patients. However, achieving this balance can be challenging due to the complexities of quality management, procurement, and temperature monitoring.
Procurement and Quality Management

Pharmaceutical companies often face pressure to maintain high profits while dealing with increasing competition and strict regulations. Reducing supply chain costs has become a key strategy to help keep profits up. However, cost-cutting must be done carefully to avoid reducing product quality, which can lead to significant financial and reputational harm.

"Keeping a high-quality supply chain for temperature-sensitive pharmaceutical products is extremely important. While managing costs is crucial for staying profitable, it should never lower the quality and safety of the products. The challenges of quality management and temperature control require careful attention to make sure that patients get safe and effective medications,” said Lie Berglind, Chief Quality Officer at TSS.

Importance of Quality Management

Quality management in life-science is more than just following regulations; it’s essential for business success. Crystal Mersh, CEO of Quality Executive Partners, recently highlighted in ‘Outsourced Pharma’, the need to invest in systems, equipment, training, and supplier quality checks. Ignoring these areas can result in poor quality products, financial losses, and damage to a company's reputation.

__wf_reserved_inherit
Quality management should be seen as a critical investment, not just an optional expense.

Crystal Mersh further elaborates that by using the Cost of Quality (COQ) concept, organizations can understand how they're using resources to prevent low quality, check products or services, and fix mistakes. This means looking at prevention, appraisal, and failure costs. When companies invest in quality management, they can reduce their overall COQ by stopping expensive mistakes and using their resources better.

Additionally, the Cost of Poor Quality (COPQ) is about the money spent because of making or delivering bad products or services. This includes costs like checking, mistakes made inside the company, and mistakes that affect customers. Quality improvement programs that work well can cut COPQ a lot, making a company more profitable and giving it long-lasting benefits. Knowing about these costs helps a company decide what to do first and reach its goals.

The Role of Temperature Monitoring

Temperature monitoring is a critical aspect of the pharmaceutical supply chain. The biopharma industry loses around $35 billion each year due to problems with temperature-controlled logistics. These losses include wasted products, disrupted clinical trials, and higher logistics costs. Additionally, compromised products can pose significant risks to patient safety. To avoid these losses, pharmaceutical companies need to invest in reliable temperature monitoring systems and technologies.

Technology, especially IoT tracking, is vital in today’s pharmaceutical supply chains. By monitoring the movement of products and important factors like temperature, companies can make informed decisions about packaging, shipping routes, inventory control, and delivery methods. End-to-end (E2E) visibility helps optimize logistical costs and ensure product integrity.

Key Strategies for Supply Chain Improvement

To tackle common issues in the pharma supply chain—such as inaccurate forecasting, long lead times, insufficient inventory, and high costs—life-science companies need to adopt strategic measures:

  1. Building Strong Relationships with Suppliers:
    Working closely with suppliers can improve reliability and flexibility, reducing lead times and ensuring a consistent supply of high-quality materials.
  2. Investing in New Technologies:
    Adopting new technologies, such as IoT for tracking and advanced analytics for forecasting, can enhance supply chain efficiency and reduce costs.
  3. Developing Robust IT Systems:
    A strong IT infrastructure is crucial for integrating different parts of the supply chain and providing the necessary visibility and control over processes.

Moving Towards a Resilient and Sustainable Supply Chain

Creating a resilient and sustainable pharmaceutical supply chain requires a focus on business outcomes through effective data collection, enhancement, and coordination. Companies need to understand how to use software and services to create a complete digital model of the supply chain. This digital model provides full visibility, allowing for better decision-making and more efficient operations.

__wf_reserved_inherit
Integrations are necessary for data visibility and automation.

"Improving the pharmaceutical supply chain is essential for ensuring the timely delivery of safe and effective medications,” Lie Berglind explained. “At TSS, we work closely with our customers to streamline operations and reduce costs. Our innovative SaaS solutions offer solid integration possibilities, providing the necessary visibility and control over the entire supply chain.”

Optimizing Cost and Quality in the Pharmaceutical Supply Chain

Balancing cost and quality in the pharmaceutical supply chain is a complex task that requires strategic investments and technological improvements. Quality management should be seen as a critical investment, not just an optional expense. Reliable temperature monitoring and supply chain visibility are essential for maintaining product quality and reducing losses.

By building strong supplier relationships, investing in new technologies, and developing robust IT systems, pharmaceutical companies can achieve a cost-effective and resilient supply chain. This approach ensures financial stability and protects patient health, ultimately benefiting everyone involved.

Analyze your supply chain using data: The combination of rich data sets, powerful analytics tools and intuitive dashboards and reports enables you to compare and analyze your supply chain and identify new cost-saving initiatives that can help transform the way you manage and handle the delivery of drugs.

     

Business analytics services >

Sources:
“A Resilient Supply Chain Starts With Full Visibility” (Forbes)
“Cost Of Quality: Worth Every Cent In Bio/Pharmaceutical Manufacturing” (Outsourced Pharma)

You may also be interested in

A collage illustrating three steps for clinical trials: vaccine vials, data analysis, and a healthcare professional.

3 steps to accelerate Decentralized trials & Release to patients

Seamless monitoring of direct-to-patient shipments within an end-to-end calculation engine enables a digital release in patient's homes. Site centric technology also allows for a decentralized and proactive approach, reducing waste. Furthermore, digitalizing temperature management end-to-end enables a faster release of products for all types of trials and creates a foundation for successful decentralized drives.
Read moreDownload Whitepaper

Turn days into seconds at clinical sites worldwide

The effective monitoring of temperature throughout the supply chain is of paramount importance in ensuring the safe and protocol-compliant conduct of a clinical trial. Each deviation causes the progress of the product along the supply chain to grind to a halt as checks are conducted to make sure it is still suitable to be dispensed.
Read moreDownload Whitepaper

Could automating temperature excursion management hold the key to improving clinical supply processes?

There are a few key reasons why many sponsors are starting to ask whether current clinical supply processes are efficient enough.
Read moreDownload Whitepaper

You may also be interested in

What Do EMA’s Updated Shortage Prevention Guidelines Mean for Pharmaceutical Leaders?

The European Medicines Agency has updated its guidance and template for Shortage Prevention Plans. For pharmaceutical leaders, the development is more than a regulatory planning exercise. It is an invitation to examine whether their organizations can identify supply vulnerabilities early and respond before an issue affects medicine availability.
Read more

Extending TempMonitor BLE to Ultra-Low Temperatures

Introducing the new TSS Dry Ice Probes, enginereed for accurate and GxP-compliant temperature monitoring down to –90°C. Available in two lengths for flexible setup — built to safeguard product integrity in every environment.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.